Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction

被引:0
作者
Temiz, Ahmet [1 ]
Gazi, Emine [1 ]
Gungor, Omer [2 ]
Barutcu, Ahmet [1 ]
Altun, Burak [1 ]
Bekler, Adem [1 ]
Binnetoglu, Emine [3 ]
Sen, Hacer [3 ]
Gunes, Fahri [3 ]
Gazi, Sabri [2 ]
机构
[1] Canakkale Onsekiz Mart Univ, Dept Cardiol, Canakkale, Turkey
[2] Canakkale State Hosp, Dept Cardiol, Canakkale, Turkey
[3] Canakkale Onsekiz Mart Univ, Dept Internal Med, Canakkale, Turkey
来源
MEDICAL SCIENCE MONITOR | 2014年 / 20卷
关键词
Myocardial Infarction; Hospital Mortality; Platelet/Lymphocyte Ratio; PLATELET VOLUME; INFLAMMATION; PREDICTOR;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Platelet-to-lymphocyte ratio (PLR) is a new prognostic marker in coronary artery disease. We aimed to evaluate the relationship between PLR and in-hospital mortality in patients with ST-elevated acute myocardial infarction (AMI). Material/Methods: The present study included 636 patients with ST-elevated AMI. The study population was divided into tertiles based on their admission PLR. Patients having values in the third tertile was defined as the high PLR group (n=212) and those having values in the lower 2 tertiles were defined as the low PLR group (n=424). Results: Risk factors of coronary artery disease and treatments administered during the in-hospital period were similar between the groups. Male patient ratio was found to be lower in the high PLR group (73% vs. 82.8%, p=0.004). In-hospital mortality was increased in the high PLR group when compared to the low PLR group (12.7% vs. 5.9%, p=0.004). The PLR > 144 was found to be an independent predictor of in-hospital cardiovascular mortality (HR: 2.16, 95% CI: 1.16-4.0, p=0.014). Conclusions: This study showed that PLR is an independent predictor of cardiovascular mortality in patients with ST-elevated AMI.
引用
收藏
页码:660 / 665
页数:6
相关论文
共 24 条
[1]   Relation of Neutrophil/Lymphocyte Ratio to Coronary Flow to In-Hospital Major Adverse Cardiac Events in Patients With ST-Elevated Myocardial Infarction Undergoing Primary Coronary Intervention [J].
Akpek, Mahmut ;
Kaya, Mehmet Gungor ;
Lam, Yat Yin ;
Sahin, Omer ;
Elcik, Deniz ;
Celik, Turgay ;
Ergin, Ali ;
Gibson, Charles Michael .
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (05) :621-627
[2]  
[Anonymous], PLOS ONE
[3]   Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction [J].
Azab, Basem ;
Shah, Neeraj ;
Akerman, Meredith ;
McGinn, Joseph T., Jr. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (03) :326-334
[4]   Mechanisms of disease:: Platelet activation and atherothrombosis [J].
Davi, Giovanni ;
Patrono, Carlo .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (24) :2482-2494
[5]  
DAVIES MJ, 1985, BRIT HEART J, V53, P363
[6]   Pathogenesis of atherosclerosis [J].
Falk, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) :C7-C12
[7]  
Fauci AS, 2008, HARRISONS PRINCIPLES, P1514
[8]   The inflammatory response in myocardial infarction [J].
Frangogiannis, NG ;
Smith, CW ;
Entman, ML .
CARDIOVASCULAR RESEARCH, 2002, 53 (01) :31-47
[9]   Platelets in inflammation and atherogenesis [J].
Gawaz, M ;
Langer, H ;
May, AE .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (12) :3378-3384
[10]  
GLUD T, 1986, ACTA MED SCAND, V220, P401